208921 Calmodulin Kinase IINtide, Myristoylated - Calbiochem

208921
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

Empirical Formula
C₂₅₆H₂₇₅N₄₇O₄₃

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
208921-1MGCN
Retrieving availability...
Limited AvailabilityLimited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      塑膠安瓿;塑膠針藥瓶 1 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewThe myristoylated form of CaMK IINtide (Cat. No. 208920). The peptide has been modified at the amino terminal lysine with the addition of three glycine residues and myristoylated to improve cell-permeability.
      Catalogue Number208921
      Brand Family Calbiochem®
      SynonymsMyr-N-GGGKRPPKLGQIGRAKRVVIEDDRIDDVLK-OH
      References
      ReferencesSodering, T.R., et al. 2001. J. Biol. Chem. 276, 3719.
      Chang, B.H., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 10890.
      Pereda, A.E., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 13272.
      Product Information
      ATP CompetitiveN
      FormWhite solid
      FormulationSupplied as a trifluoroacetate salt.
      Hill FormulaC₂₅₆H₂₇₅N₄₇O₄₃
      Chemical formulaC₂₅₆H₂₇₅N₄₇O₄₃
      Hygroscopic Hygroscopic
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetCalmodulin-Dependent Protein Kinase (CaM Kinase)-2
      Primary Target IC<sub>50</sub>50 nM against cam Kinase-2
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Peptide SequenceMyr-N-Gly-Gly-Gly-Lys-Arg-Pro-Pro-Lys-Leu-Gly-Gln-Ile-Gly-Arg-Ala-Lys-Arg-Val-Val-Ile-Glu-Asp-Asp-Arg-Ile-Asp-Asp-Val-Leu-Lys-OH
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at-20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Calmodulin Kinase IINtide, Myristoylated - Calbiochem MSDS

      Title

      Safety Data Sheet (SDS) 

      Calmodulin Kinase IINtide, Myristoylated - Calbiochem Certificates of Analysis

      TitleLot Number
      208921

      References

      Reference overview
      Sodering, T.R., et al. 2001. J. Biol. Chem. 276, 3719.
      Chang, B.H., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 10890.
      Pereda, A.E., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 13272.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision28-May-2008 RFH
      SynonymsMyr-N-GGGKRPPKLGQIGRAKRVVIEDDRIDDVLK-OH
      DescriptionThe myristoylated form of CaMK IINtide (Cat. No. 208920), a potent, specific inhibitor of Ca2+/Calmodulin kinase II (CaMK II) (IC50 = 50 nM for total and Ca2+-independent CaMK II activity). The peptide sequence corresponds to the inhibitory domain of the CaMK II inhibitory protein, CaMK IIN. Exhibits inhibitory activity across converged species, including rat brain, goldfish brain, and Drosophila (IC50 = 100-400 nM). Shown to completely inhibit the phosphorylation of GluR1 fusion protein at a concentration of 1 µM. Does not inhibit CaMK I, CaMK IV, CaMKK, PKA, or PKC. The peptide has been modified at the amino terminal lysine with the addition of three glycine residues and myristoylated to improve cell-permeability.
      FormWhite solid
      FormulationSupplied as a trifluoroacetate salt.
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₂₅₆H₂₇₅N₄₇O₄₃
      Peptide SequenceMyr-N-Gly-Gly-Gly-Lys-Arg-Pro-Pro-Lys-Leu-Gly-Gln-Ile-Gly-Arg-Ala-Lys-Arg-Val-Val-Ile-Glu-Asp-Asp-Arg-Ile-Asp-Asp-Val-Leu-Lys-OH
      Purity≥95% by HPLC
      SolubilityDMSO (5 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at-20°C.
      Toxicity Standard Handling
      ReferencesSodering, T.R., et al. 2001. J. Biol. Chem. 276, 3719.
      Chang, B.H., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 10890.
      Pereda, A.E., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 13272.